Skip to main content

Want a detailed portfolio tracker?

Sensei Biotherapeutics (SNSE) P/E (2021 - 2026)

Sensei Biotherapeutics (SNSE) P/E from Feb 4, 2021 to Jun 16, 2026. The TTM Sensei Biotherapeutics (SNSE) P/E is -0.11. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Sensei Biotherapeutics (SNSE)

YearP/EChange
2026-0.11-83.53%
2025-0.64+56.17%
2024-0.41-19.46%
2023-0.51-49.28%
2022-1.00-79.26%
2021-4.82N/A

Comparison Sensei Biotherapeutics (SNSE) P/E with competitors

Sensei Biotherapeutics (SNSE) P/E is -0.11.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-101.62%
NBYStablecoin Development Corp0.00-104.09%
ENLVEnlivex Ltd0.07-171.19%
FGENFibroGen Inc0.24-328.46%
CHRSCoherus Biosciences Inc0.85-907.59%
FBIOFortress Biotech Inc0.95-1003.24%
ORMPOramed Pharmaceuticals Inc1.50-1530.53%
AGENAgenus Inc3.01-2964.39%
INVAInnoviva Inc3.15-3101.83%
VXRTVaxart Inc3.55-3478.45%
CRMDCorMedix Inc3.63-3553.36%
CVACCureVac N.V.4.45-4331.15%
GLPGGalapagos NV4.86-4724.43%
SRPTSarepta Therapeutics Inc4.88-4746.51%
ABEOAbeona Therapeutics Inc5.39-5227.54%
ABUSArbutus Biopharma Corp5.60-5425.61%
ZVRAZevra Therapeutics Inc5.89-5703.15%
SPROSpero Therapeutics Inc6.23-6027.90%
CGENCompugen Ltd6.31-6109.28%
RIGLRigel Pharmaceuticals6.87-6640.47%
SLXNSilexion Therapeutics Corp7.30-7044.02%
OMEROmeros Corporation9.26-8911.99%
AUPHAurinia Pharmaceuticals Inc9.58-9222.46%
PLXProtalix BioTherapeutics Inc10.89-10465.49%
ACADAcadia Pharmaceuticals Inc11.73-11262.61%
TBPHTheravance Biopharma Inc12.26-11770.48%
ADMAAdma Biologics Inc12.42-11918.96%
HRMYHarmony Biosciences Holdings Inc13.82-13253.36%
SABSSAB Biotherapeutics Inc14.14-13554.13%
NAGENiagen Bioscience Inc14.82-14203.15%
INCYIncyte Corp15.82-15159.12%
REGNRegeneron Pharmaceuticals Inc15.86-15191.57%
PBYIPuma Biotechnology Inc17.32-16580.23%
CPRXCatalyst Pharmaceuticals Inc17.44-16697.87%
EXELExelixis Inc17.54-16791.81%
TGTXTG Therapeutics Inc18.97-18150.95%
MDXGMimedx Group Inc20.55-19660.86%
XOMAXOMA Royalty Corp22.87-21871.57%
ARGXArgen X SE24.30-23226.24%
CTMXCytomX Therapeutics Inc24.82-23724.12%
XOMAOXOMA Royalty Corp25.34-24222.57%
HALOHalozyme Therapeutics Inc25.62-24488.02%
XOMAPXOMA Royalty Corp25.67-24532.19%
VRTXVertex Pharmaceuticals Inc27.99-26744.70%
RPRXRoyalty Pharma plc - Class A28.69-27404.10%
SLNOSoleno Therapeutics Inc29.02-27716.09%
ASNDAscendis Pharma A/S30.09-28734.69%
LGNDLigand Pharmaceuticals Inc - Class B37.91-36183.73%
APLSApellis Pharmaceuticals Inc39.02-37239.45%
BMRNBiomarin Pharmaceutical Inc42.21-40276.21%
KRYSKrystal Biotech Inc45.34-43256.81%
ONCBeiGene Ltd69.54-66286.93%
PHARPharming Group N.V.75.03-71507.56%
TECHBio-Techne Corp101.96-97141.56%
VCELVericel Corp109.92-104720.52%
ALNYAlnylam Pharmaceuticals Inc117.96-112376.38%
GMABGenmab140.29-133625.42%
TLXTelix Pharmaceuticals Ltd162.15-154433.22%
CORTCorcept Therapeutics Inc212.86-202692.73%